Galectin Therapeutics Receives Patent

Galectin Therapeutics Receives Patent

Galectin Therapeutics has received a U.S. Patent for “Method of Enhancing Specific Immunotherapies in Cancer Treatment.” Members of Galectin and Providence Cancer Center in Portland, Ore. are joint inventors on the patent, and Galectin holds the exclusive license. The patent’s principal claims cover method of use of GR-MD-02 as a means to enhance anti-tumor activity and increase survival effects of combining GR-MD-02 with multiple clinically relevant types of immune modulators, […]

Read More ˃
U.S. Rig Count Rises

U.S. Rig Count Rises

The number of oil and gas rigs operating in the US rose for a 19th consecutive week to 908, the highest level since April of 2015, according to the weekly tally by oil field services firm Baker Hughes (BHI). The North American total rose to 1,001 in the period to Friday from 986 a week ago, the company said. The Canada oil and gas count increased to 93 from 85 […]

Read More ˃
Sunworks Signs Strategic Partnership

Sunworks Signs Strategic Partnership

Sunworks shares rose 10% in pre-market trade after the provider of solar power systems and equipment said it has signed a strategic marketing partnership with Quantum Spatial, an independent geospatial data firm. Financial terms of the deal were not disclosed. “This new relationship with Quantum Spatial will enhance our growth in the federal and commercial markets as a result of their superb technical prowess and exemplary reputation with their domestic […]

Read More ˃
Cabot Hikes Prices for Fine Cesium Chemicals

Cabot Hikes Prices for Fine Cesium Chemicals

Cabot, a specialty chemicals and performance materials company, said pre-market Wednesday that it will increase prices by up to 18% for its fine cesium chemicals product portfolio, effective April 12. The company said in a statement that demand for its fine cesium chemicals products increased in late 2016 and has continued into 2017. Cabot said this price adjustment is required to support ongoing investments in its fine cesium chemicals manufacturing […]

Read More ˃
Stock Rally Stalls as Profit-Taking Accelerates

Stock Rally Stalls as Profit-Taking Accelerates

The benchmark averages were trading in negative territory with lower oil prices and lingering concerns about over-valuations putting the brakes on a ten-day rally in the Dow. For the week, the Dow was positioned to close higher for a third straight week, while the S&P 500 should extend its winning streak to week five. Losses for the Nasdaq will result in a lower close after four weeks higher. Investor’s appetite […]

Read More ˃